First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

Clinical trial NCT00537901 · COMPLETED

Trial details

NCT number: NCT00537901
Sponsor: King Faisal Specialist Hospital & Research Center
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Colonic Neoplasms Rectal Neoplasms

Start date: 2007-10-01
Primary completion: 2013-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.